Related references
Note: Only part of the references are listed.Effect of RU486 on Hepatic and Adipocyte Gene Expression Improves Diabetes Control in Obesity-type 2 Diabetes
A. I. Taylor et al.
HORMONE AND METABOLIC RESEARCH (2009)
Metyrapone prevents cortisone-induced preadipocyte differentiation by depleting luminal NADPH of the endoplasmic reticulum
Paola Marcolongo et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Adipose tissue 11-beta-Hydroxysteroid Dehydrogenase Type 1 and Hexose-6-Phosphate Dehydrogenase gene expressions are increased in patients with type 2 diabetes mellitus
Gkhan Uckaya et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Insulin and dexamethasone dynamically regulate adipocyte 11β-hydroxysteroid dehydrogenase type 1
Aran Balachandran et al.
ENDOCRINOLOGY (2008)
Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice
Yanjun Liu et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2008)
11β-hydroxysteroid dehydrogenase type 1 regulation by intracellular glucose 6-phosphate provides evidence for a novel link between glucose metabolism and Hypothalamo-Pituitary-Adrenal axis function
Elizabeth A. Walker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The glucose-6-phosphate transporter-hexose-6-phosphate dehydrogenase-11β-hydroxysteroid dehydrogenase type 1 system of the adipose tissue
Paola Marcolongo et al.
ENDOCRINOLOGY (2007)
Bezafibrate regulates the expression and enzyme activity of 11β-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes
Shigeru Nakano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Increased 11β-hydroxysteroid dehydrogenase type-1 and hexose-6-phosphate dehydrogenase in liver and adipose tissue of rat offspring exposed to alcohol in utero
Srinivas Nammi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice
Yanjun Liu et al.
ENDOCRINOLOGY (2006)
Inhibitory effect of phenolic acids on the proliferation of 3T3-L1 preadipocytes in relation to their antioxidant activity
Chin-Lin Hsu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)
Inhibition of 11β-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice
SJY Wang et al.
DIABETOLOGIA (2006)
Hexose-6-phosphate dehydrogenase knock-out mice lack 11β-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation
GG Lavery et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Uncoupled redox systems in the lumen of the endoplasmic reticulum -: Pyridine nucleotides stay reduced in an oxidative environment
S Piccirella et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Evidence that the 11 β-hydroxysteroid dehydrogenase (11 β-HSD1) is regulated by pentose pathway flux -: Studies in rat adipocytes and microsomes
KL McCormick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Minireview:: Hexose-6-phosphate dehydrogenase and redox control of 11β-hydroxysteroid dehydrogenase type 1 activity
KN Hewitt et al.
ENDOCRINOLOGY (2005)
Increased glucocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice
YJ Liu et al.
DIABETES (2005)
Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxoreductase
AG Atanasov et al.
FEBS LETTERS (2004)
Cooperativity between 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum
G Bánhegyi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus
C Opherk et al.
MOLECULAR ENDOCRINOLOGY (2004)
Metabolic syndrome without obesity:: Hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice
JM Paterson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency
N Draper et al.
NATURE GENETICS (2003)
Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice
YJ Liu et al.
DIABETES (2003)
11 beta-hydroxysteroid dehydrogenase activity in hypothalamic obesity
D Tiosano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Effects of the 11 beta-hydroxysteroid dehydrogrenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes
RC Andrews et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
P Alberts et al.
DIABETOLOGIA (2002)
The glucose-6-phosphatase system
E Van Schaftingen et al.
BIOCHEMICAL JOURNAL (2002)
A transgenic model of visceral obesity and the metabolic syndrome
H Masuzaki et al.
SCIENCE (2001)
Glucocorticoids activate transcription of the gene for the glucose-6-phosphate transporter, deficient in glycogen storage disease type 1b
H Hiraiwa et al.
DNA AND CELL BIOLOGY (2001)
Minireview:: 11β-hydroxysteroid dehydrogenase type 1 -: A tissue-specific amplifier of glucocorticoid action
JR Seckl et al.
ENDOCRINOLOGY (2001)
Obesity and insulin resistance
BB Kahn et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
